Partnership sees launch of BevCanna products under Stigma Grow’s Sales License across Canada
RED DEER, AB, March 15, 2021 /CNW/ – Stigma Grow (“Stigma” or the “Company”) and their parent company CanadaBis Capital Inc. (TSX-V: CANB) are pleased to announce they have formed a partnership with beverage and natural products company, BevCanna Enterprises Inc. (CSE: BEV) (Q: BVNNF) (FSE: 7BC) (BevCanna“) to launch the award-winning Keef Brands line of cannabis-infused beverages across Canada, along with BevCanna’s in-house and white label client products under Stigma Grow’s sales license.
Execution of this Sales License Partnership will streamline BevCanna’s product commercialization and fast-track their Canadian market penetration, as Stigma’s established network of buyers and distributors provides a valuable pathway to market.
“We’re happy to partner with BevCanna in launching their portfolio of products across Canada,” said Travis McIntyre, CEO of Stigma Grow. “We are in the unique position of understanding the value that can come with aligning with the right-fit partners as we all navigate our market entrances. We feel that the brand culture and business acumen were both good fits with BevCanna.”
By leveraging the mix of Stigma’s existing Canada-wide distribution network, growing line-up of in-demand BHO (butane hash oil) concentrate brands, and the addition of BevCanna’s diverse portfolio of products under Stigma’s license, the Company is creating a more exciting and robust story to tell as it continues to introduce itself, and its partners, to new retail customers across the country.
About Stigma Grow
Stigma Grow is a cutting-edge cannabis cultivation and BHO extraction company positioned advantageously to strive to meet the unmet market demands and stigmas within the legal cannabis industry head on, with products designed to disturb the status quo and dramatically shift the conversation surrounding Canada’s legal cannabis industry.
About BevCanna Enterprises Inc.
BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) is a diversified health & wellness beverage and natural products company. BevCanna develops and manufactures a range of plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. Based in British Columbia, Canada, BevCanna owns a pristine alkaline spring water aquifer and a world–class 40,000–square–foot, HACCP certified manufacturing facility. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with #1 U.S. cannabis beverage company Keef Brands.
About CanadaBis Capital Inc.
CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated Canadian cannabis company focused on achieving large-scale growth in the fast-emerging global cannabis market. By targeting organic growth opportunities alongside the right-fit partners, we remain focused on finding and capitalizing on chances to grow, diversify and continue to lead our industry.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include but are not limited to statements with respect to our business and operations; timing of the Company’s profitability; the demand and sales volumes of the Company’s products, and our general business plans. Forward-looking statements are necessarily based upon a number of assumptions including: the ability of the Company’s products to compete with the pricing and product availability on the black-market; the market demand for the Company’s products; and assumptions concerning the Company’s competitive advantages. These assumptions, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: compliance with extensive government regulation, the general business, economic, competitive, political and social uncertainties; ability to sustain or create a demand for a product; requirement for further capital; delay or failure to receive board, shareholder or regulatory approvals; the results of operations and such other matters as set out in the Company’s continuous disclosure on SEDAR at www.sedar.com. There can be n no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.
Accordingly, readers should not place undue reliance on forward-looking statements. Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although we believe that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have a material adverse effect on our future results, performance or achievements.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE CanadaBis Capital Inc.
For further information: Investor Relations: Info@CanadaBis.com, 1-888-STIGMA1